Author details

Full Name

Jeanne C Latourelle

Affiliation

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33938021	Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease.	Ann Neurol	2021
29282329	MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study.	Neurology	2018
30175238	Meta-analysis of exome array data identifies six novel genetic loci for lung function.	Wellcome Open Res	2018
30061609	Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function.	Nat Commun	2018
30205856	Meta-analysis across Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium provides evidence for an association of serum vitamin D with pulmonary function.	Br J Nutr	2018
28166215	Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis.	Nat Genet	2017
28958801	Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.	Lancet Neurology, The	2017
28190298	miR-149 and miR-29c as candidates for bipolar disorder biomarkers.	Am J Med Genet B Neuropsychiatr Genet	2017
27508417	The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane.	PLoS One	2016
26973511	microRNA Profiles in Parkinson's Disease Prefrontal Cortex.	Frontiers in Aging Neuroscience	2016
26881370	Association Between Interstitial Lung Abnormalities and All-Cause Mortality.	JAMA	2016
27096366	Parkinson-associated risk variant in distal enhancer of Î±-synuclein modulates target gene expression.	Nature	2016
26793951	Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease.	BMC Medical Genomics	2016
27314401	Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.	Am J Respir Crit Care Med	2016
26771117	Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities.	Am J Respir Crit Care Med	2016
27476799	Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2.	J Bone Miner Res	2016
27454300	Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression.	PLoS One	2016
27692902	DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.	Lancet Neurol	2016
26573701	Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.	Movement Disorders	2015
25889241	miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.	BMC Med Genomics	2015
25868675	Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities.	Eur J Radiol	2015
26514822	A comparison of visual and quantitative methods to identify interstitial lung abnormalities.	BMC Pulm Med	2015
26636579	RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression.	PLoS One	2015
24586208	MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.	PLoS Genet	2014
23692170	MUC5B promoter polymorphism and interstitial lung abnormalities.	N Engl J Med	2013
23644918	Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset.	Neurogenetics	2013
23599501	Network-guided sparse regression modeling for detection of gene-by-gene interactions.	Bioinformatics	2013
23071545	Evaluation of Parkinson disease risk variants as expression-QTLs.	PLoS ONE	2012
22438815	Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.	PLoS Genet	2012
22837378	Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction.	Am J Respir Crit Care Med	2012
22530163	Postmortem Interval Influences Î±-Synuclein Expression in Parkinson Disease Brain.	Parkinson's Disease	2012
22825315	Population stratification may bias analysis of PGC-1Î± as a modifier of age at Huntington disease motor onset.	Hum Genet	2012
22451204	Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.	Ann Neurol	2012
22761592	Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation.	PLoS Genet	2012
23035064	Assessment of cortical and striatal involvement in 523 Huntington disease brains.	Neurology	2012
21829596	Copy number variation in familial Parkinson disease.	PLoS One	2011
21258085	Cyclin-G-associated kinase modifies Î±-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study.	Hum Mol Genet	2011
21661047	Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.	Mov Disord	2011
20385012	Risk of Parkinson's disease after tamoxifen treatment.	BMC Neurology	2010
20865113	Estrogen-related and other disease diagnoses preceding Parkinson's disease.	Clinical Epidemiology	2010
18985386	Genomewide association study for susceptibility genes contributing to familial Parkinson disease.	Hum Genet	2009
19461589	Multiple genes influence BMI on chromosome 7q31-34: the NHLBI Family Heart Study.	Obesity (Silver Spring)	2009
19507258	Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).	American Journal of Medical Genetics, Part A	2009
19772629	Genomewide association study for onset age in Parkinson disease.	BMC Med Genet	2009
18587682	Replication of association between ELAVL4 and Parkinson disease: the GenePD study.	Hum Genet	2008
18986508	The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.	BMC Med	2008
18509094	Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.	Neurology	2008
18649400	Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.	Mov Disord	2008
18498660	Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study.	BMC Med Genet	2008
18317470	NYD-SP18 is associated with obesity in the NHLBI Family Heart Study.	Int J Obes (Lond)	2008